CHSU Discovery

Abstract

• Benign prostatic hyperplasia (BPH) is a common age-related condition in men over 50, driven by hormonal changes and associated with risk factors such as obesity and metabolic disease. It typically presents with lower urinary tract symptoms (LUTS), including frequency, urgency, weak stream, nocturia, and incomplete emptying.¹
• Initial management includes lifestyle modifications and medical therapy with alpha-blockers and 5-alpha-reductase inhibitors. For refractory cases, procedural options include TURP, Rezum, prostatic artery embolization, and prostatic urethral lift (UroLift).¹
• UroLift is a minimally invasive procedure that uses permanent implants to retract prostatic tissue and relieve urethral obstruction, with advantages including preservation of sexual function and rapid recovery.²
• Although generally well tolerated, adverse effects include hematuria, dysuria, pelvic pain, and transient urinary retention. Rare complications such as implant migration, misplacement, and encrustation can lead to delayed sequelae.³
• We present a case of delayed UroLift implant migration with bladder mucosal penetration, resulting in persistent LUTS and chronic inflammation requiring repeat surgical intervention.